Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C085911 |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Triiodothyronine affects the expression of TTN mRNA] | affects expression|decreases reaction | 18096819
|
C518576 |
2-methylbutyric acid 4-((1,3)dioxan-5-ylmethoxyimino)-8-(2-(4-hydroxy-6-oxo-tetrahydropyran-2-yl)ethyl -7-methyl-6-oxo-1,2,3,4,6,7,8,8a-octahydronaphthyl)heptanoate |
2-methylbutyric acid 4-((1,3)dioxan-5-ylmethoxyimino)-8-(2-(4-hydroxy-6-oxo-tetrahydropyran-2-yl)ethyl -7-methyl-6-oxo-1,2,3,4,6,7,8,8a-octahydronaphthyl)heptanoate results in decreased expression of TTN mRNA | decreases expression | 17327690
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of TTN mRNA | affects expression | 17562736
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of TTN mRNA | affects expression | 16483693
|
C006780 |
bisphenol A |
bisphenol A results in increased expression of TTN mRNA | increases expression | 18180321
|
C055494 |
caffeic acid phenethyl ester |
[Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of TTN mRNA | affects cotreatment|decreases expression | 20360939
|
D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of TTN mRNA | affects cotreatment|decreases expression | 20360939
|
D014284 |
Triiodothyronine |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Triiodothyronine affects the expression of TTN mRNA] | affects expression|decreases reaction | 18096819
|
D014284 |
Triiodothyronine |
AKT1 protein affects the reaction [Triiodothyronine affects the expression of TTN mRNA] | affects expression|affects reaction | 18096819
|
D014284 |
Triiodothyronine |
Triiodothyronine affects the expression of TTN mRNA | affects expression | 18096819
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.90 | 18287403 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
2.98 | 10737359 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
4.24 | 17620307 16434500 17162532 18056438 19061943 19052882 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
4.22 | 10982225 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.40 | 18445737 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
4.10 | 11985600 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
2.22 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
2.22 | 17474063 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
2.94 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
2.94 | 16779866 20524982 16288022 20935162 17978847 16935385 19171122 16681979 3084413 18494052 19701751 16328049 18210153 19418558 19539802 16830150 19335982 16569478 19052882 10737359 18506893 17162532 19822196 16540662 21159647 17428255 18393292 20214788 17138121 16698587 20007298 20514400 17761372 19383236 17173139 10672840 3581430 16502159 19919837 20084675 19208518 18971187 18978308 18665156 19519916 11831363 20432363 18788625 20727157 18691550 20512989 16878318 16807293 18785209 20101231 18056438 17055752 19107877 19394651 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
5.33 | 17123778 |
MESH:D002311 |
Cardiomyopathy, Dilated |
marker/mechanism |
|
| |
MESH:D024741 |
Cardiomyopathy, Hypertrophic, Familial |
marker/mechanism |
|
| |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.71 | 10977129 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
3.01 | 21159647 7505956 2727394 17174075 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
3.90 | 19052882 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
2.23 | 20387270 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
3.94 | 16081117 11421492 19923254 14725611 19164858 17906064 15619225 12705907 16485898 16781746 14986274 10663392 19420014 11739529 17562736 19416960 10774834 11743745 16393943 18071297 2444490 16177239 16109766 11461765 12594235 17522070 11834606 14550746 12958197 18713872 19370779 19085960 16227642 11529661 12392966 10915739 15968718 11287661 12540782 19739265 12153990 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
3.94 | 19107877 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
4.47 | 19426721 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
5.49 | 16302075 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
3.43 | 21071580 20387270 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
4.05 | 16983495 |
OMIM:603689 |
HEREDITARY MYOPATHY WITH EARLY RESPIRATORY FAILURE |
marker/mechanism |
|
| |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
2.89 | 16870215 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
2.48 | 18785209 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
3.44 | 16393666 |
MESH:D007414 |
Intestinal Neoplasms |
|
caffeic acid phenethyl ester |
4.81 | 10783313 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
6.66 | 12587719 15629191 |
MESH:D007674 |
Kidney Diseases |
|
caffeic acid phenethyl ester |
6.66 | 15369732 |
MESH:D007938 |
Leukemia |
|
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one |
3.91 | 12970779 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
caffeic acid phenethyl ester |
4.14 | 16766008 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
2.94 | 18665156 19638242 18522880 18407596 20032147 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
4.08 | 12969438 11587558 16611625 12587719 19784758 16610002 19014921 19460945 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
4.08 | 17034775 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.46 | 17185352 16871587 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
2.31 | 19642983 19690152 19090486 19812893 19833225 16942905 15175105 19638242 19255062 19073162 18648771 21278145 19996281 19426721 2422723 19427195 20101389 12112319 9163691 19499222 20118626 20137499 19551842 21047994 10737359 18754104 20492335 20452335 20434301 18644402 20405173 12771043 19850985 2862719 18977376 15885732 18978307 19294768 19254457 20583210 19256749 21167192 21071580 20501860 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
2.77 | 3124819 18164116 18079962 18308698 18775883 17854601 19126423 17174075 18544905 18093689 18253720 19519916 17942915 21159647 19009564 16267830 9362446 19004024 16842330 18282651 19539802 2563599 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
1.76 | 20970405 21163286 20512841 6695378 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.87 | 19513568 |
OMIM:608807 |
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2J |
marker/mechanism |
|
| |
OMIM:611705 |
MYOPATHY, EARLY-ONSET, WITH FATAL CARDIOMYOPATHY |
marker/mechanism |
|
| |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
2.65 | 3581430 9029167 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
4.25 | 16427766 11399458 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
8.86 | 18514411 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
8.86 | 20387270 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
5.49 | 20387270 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
5.33 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one |
3.44 | 16211241 |
MESH:D010146 |
Pain |
|
Acetaminophen |
2.59 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
2.49 | 16540662 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
3.77 | 2563599 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
4.29 | 10548101 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
4.45 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
3.37 | 16740699 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
5.12 | 10548101 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
1.76 | 18456281 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
4.32 | 16045194 16684133 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
3.16 | 7505956 |
OMIM:600334 |
TIBIAL MUSCULAR DYSTROPHY, TARDIVE |
marker/mechanism |
|
| |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
3.24 | 10982225 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
5.38 | 14652134 |